Aortic Valve Stenosis Clinical Trials in San Francisco, California

4 studies are recruiting for aortic valve stenosis in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

    The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve.

    Stage
    Not phased
    Ages
    Any age
    Site
    Bay Area Structural Heart at Sutter Health, San Francisco, California
    Locations
    37 in total
    Run by
    Edwards Lifesciences

    See if you can join NCT05172973 on ClinicalTrials.gov

  2. Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

    Data on valve performance following ViV-TAVR has usually been obtained with the use of Doppler-echocardiography. However, some reports have shown significant discordances in the evaluation of mean transvalvular gradient between echocardiography and catheterization, with an overestimation of the rea…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California, San Francisco, California
    Locations
    7 in total
    Run by
    Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

    See if you can join NCT05459233 on ClinicalTrials.gov

  3. PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

    This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in …

    Stage
    Not phased
    Ages
    65 and older
    Site
    Bay Area Structural Heart at Sutter Health, San Francisco, California
    Locations
    80 in total
    Run by
    Edwards Lifesciences

    See if you can join NCT04889872 on ClinicalTrials.gov

  4. Effect of Fetal Aortic Valvuloplasty on Outcomes

    In one of the most severe congenital heart defects, hypoplastic left heart syndrome (HLHS), the left ventricle is underdeveloped and the prognosis is worse than in most other heart defects. The underdevelopment can occur gradually during fetal growth caused by a narrowing of the aortic valve. At so…

    Stage
    Not phased
    Ages
    0 to 0
    Site
    Fetal Cardiovascular Program, University of California San Francisco, San Francisco, California
    Locations
    13 in total
    Run by
    Queen Silvia Children's Hospital, Gothenburg, Sweden

    See if you can join NCT05386173 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.